News

Awards, honors, prizes and achievements for the month of June.

Amanda Garfinkel, a third-year medical student at Weill Cornell Medical College, was awarded a one-year fellowship from the Sarnoff Cardiovascular Research Foundation.

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy’s ability to trigger an immune response against cancer.

In Dr. Stuart Mushlin's new book, "Playing the Ponies and Other Medical Mysteries Solved," he reflects on cases from his more than 40 years of practice and presents his patients not just as cases but as people along with details of their conditions. 

The first-ever “disease in a Petri dish” platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.

A calcium-dependent molecular mechanism discovered in the brain cells of mice by Weill Cornell Medicine investigators may underlie the impaired social interactions and anxiety found in neuropsychiatric disorders — including schizophrenia and autism.

Mass incarceration is now widely acknowledged as a major problem in our society — and one that professionals in law enforcement, education, public policy, and government are working to address. Dr. Ross MacDonald ’03, MD ’08 is tackling this issue from a public health perspective.

Dr. Conor Liston, an assistant professor of neuroscience in the Feil Family Brain and Mind Institute and an assistant professor of psychiatry at Weill Cornell Medicine, has been named a Rita Allen Foundation Scholar.

Dr. Christine Salvatore has been named chief of the Division of Pediatric Infectious Diseases in the Department of Pediatrics at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine.

When Dr. Olorunseun Ogunwobi, an associate professor of biology at Hunter College and adjunct assistant professor at Weill Cornell Medicine needed African-American men to participate in his research on how genetics might play a role in prostate cancer disparities, he reached out to a well-known Bronx community leader to help him establish relationships with potential participants.

Dr. Choi came to the United States with his parents and three siblings when he was 12, settling in Kentucky. He earned his undergraduate degree from the University of Kentucky and his medical degree from the University of Louisville.

New imaging methods that allow researchers to track the individual protein molecules on the surface of cells have been developed by Weill Cornell Medicine investigators. The results offer unprecedented insight into how cells sense and respond to their environments. 

Dr. Nicole Cruz, a senior resident in the Residency Training Program in Internal Medicine at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, has been named the National Hispanic Medical Association Resident of the Year for the northeast region.

A technique developed by Weill Cornell Medicine and NewYork-Presbyterian investigators can detect cancer cells surviving therapy in the most common form of leukemia in adults more sensitively and precisely than traditional microscopic observation.

Dr. Ralf Holzer, a pediatric cardiologist and expert in minimally invasive techniques to treat children and adults with congenital heart disease, has been named chief of the Division of Pediatric Cardiology and director of Pediatric Cardiac Catheterization at the Phyllis and David Komansky Center for Children’s Health at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine.

Atrial fibrillation is a condition that affects as many as 6.1 million Americans and is characterized by an irregular, often rapid heart rate caused by a misfiring of electrical impulses. 

On the eve of their commencement, students from Weill Cornell Medical College and Weill Cornell Graduate School of Medical Sciences were recognized for their outstanding achievements.

Dr. Carl Nathan, the incoming dean of the Weill Cornell Graduate School of Medical Sciences, has won a 2017 Heritage Healthcare Innovation Award.

NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the United States that uses a small molecule to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy.